Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Alpine Immune Sciences Inc.

Alpine Immune Sciences Announces Participation in September Investor Conferences

September 06, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Tickers ALPN

Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303

August 10, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Tickers ALPN EVO

Alpine Immune Sciences Appoints Jörn Drappa, MD, PhD, to Board of Directors

July 19, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Tickers ALPN

Alpine Immune Sciences Announces Update on ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus Erythematosus and Other Autoimmune and Inflammatory Diseases, at EULAR 2022

June 01, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Tickers ALPN

AACR 2022: Davoceticept (ALPN-202) Monotherapy Reduces Tumors, Supports Multiple Expansion Cohorts

April 12, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Tickers ALPN

Alpine Immune Sciences Announces Company Presentation and Update on AACR Investor Event

April 05, 2022

From Alpine Immune Sciences Inc.

Via Business Wire

Tickers ALPN

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions